CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals.[ Read More ]
The intrinsic value of one CVS stock under the base case scenario is HIDDEN Compared to the current market price of 53.2 USD, CVS Health Corporation is HIDDEN
Current Assets | 67.9 B |
Cash & Short-Term Investments | 11.5 B |
Receivables | 35.2 B |
Other Current Assets | 21.2 B |
Non-Current Assets | 182 B |
Long-Term Investments | 23 B |
PP&E | 30.4 B |
Other Non-Current Assets | 128 B |
Current Liabilities | 79.2 B |
Accounts Payable | 14.9 B |
Short-Term Debt | 4.71 B |
Other Current Liabilities | 59.6 B |
Non-Current Liabilities | 93.9 B |
Long-Term Debt | 90.7 B |
Other Non-Current Liabilities | 3.2 B |
Revenue | 358 B |
Cost Of Revenue | 303 B |
Gross Profit | 54.4 B |
Operating Expenses | 40.7 B |
Operating Income | 13.7 B |
Other Expenses | 5.38 B |
Net Income | 8.37 B |
Net Income | 8.37 B |
Depreciation & Amortization | 4.37 B |
Capital Expenditures | -3.03 B |
Stock-Based Compensation | 588 M |
Change in Working Capital | 15 M |
Others | -453 M |
Free Cash Flow | 10.4 B |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
6 months ago
May 02, 2024
|
Bought 53.9 K USD
|
LUDWIG EDWARD J
Director |
+ 1000
|
53.879 USD |
6 months ago
May 02, 2024
|
Bought 500 K USD
|
Mahoney Michael F
Director |
+ 9181
|
54.4923 USD |
9 months ago
Feb 16, 2024
|
Sell 2.27 M USD
|
Shah Prem S
EVP and Pres-Pharm, Consumer W |
- 29473
|
76.95 USD |
1 year ago
Nov 03, 2023
|
Bought 141 K USD
|
LUDWIG EDWARD J
Director |
+ 2000
|
70.465 USD |
1 year ago
Aug 03, 2023
|
Sell 197 K USD
|
Clark James David
SVP, Cont & Chief Acct Officer |
- 2631.255
|
74.79 USD |
1 year ago
Aug 03, 2023
|
Sell 1.73 M USD
|
Clark James David
SVP, Cont & Chief Acct Officer |
- 23128
|
74.94 USD |
1 year ago
May 03, 2023
|
Bought 977 K USD
|
Lynch Karen S
President and CEO |
+ 14000
|
69.7548 USD |
1 year ago
Dec 15, 2022
|
Sell 3.58 M USD
|
Moriarty Thomas M
EVP & General Counsel |
- 36490
|
98.2425 USD |
2 years ago
Aug 03, 2022
|
Sell 6.9 M USD
|
Lotvin Alan
EVP&President-PharmacyServices |
- 70398
|
98 USD |
2 years ago
Aug 03, 2022
|
Sell 955 K USD
|
Finke Daniel P
EVP/Pres, Health Care Benefits |
- 9546
|
100 USD |
2 years ago
Jun 28, 2022
|
Sell 4.8 M USD
|
Moriarty Thomas M
EVP & General Counsel |
- 50502
|
95 USD |
2 years ago
Apr 08, 2022
|
Sell 600 K USD
|
Shah Prem S
EVP and Co-President of Retail |
- 5719
|
105 USD |
2 years ago
Apr 04, 2022
|
Sell 1.62 M USD
|
Finke Daniel P
EVP/Pres, Health Care Benefits |
- 16161
|
100.13 USD |
2 years ago
Mar 30, 2022
|
Sell 560 K USD
|
Shah Prem S
EVP and Co-President of Retail |
- 5346
|
104.7 USD |
2 years ago
Mar 17, 2022
|
Sell 313 K USD
|
Shah Prem S
EVP and Co-President of Retail |
- 2935
|
106.65 USD |
2 years ago
Mar 15, 2022
|
Sell 5.39 M USD
|
Moriarty Thomas M
EVP & General Counsel |
- 51361
|
105 USD |
2 years ago
Feb 10, 2022
|
Bought 106 K USD
|
LUDWIG EDWARD J
Director |
+ 1000
|
105.9044 USD |
2 years ago
Feb 10, 2022
|
Bought 106 K USD
|
LUDWIG EDWARD J
Director |
+ 1000
|
105.9044 USD |
2 years ago
Feb 03, 2022
|
Sell 5.27 M USD
|
Brennan Troyen A
EVP and Chief Medical Officer |
- 47937
|
110 USD |
2 years ago
Feb 01, 2022
|
Sell 2.28 M USD
|
Lotvin Alan
EVP&President-PharmacyServices |
- 21386
|
106.498 USD |
2 years ago
Jan 28, 2022
|
Sell 660 K USD
|
Clark James David
SVP, Cont & Chief Acct Officer |
- 6059
|
109 USD |
2 years ago
Jan 28, 2022
|
Sell 660 K USD
|
Clark James David
SVP, Cont & Chief Acct Officer |
- 6059
|
109 USD |
2 years ago
Jan 27, 2022
|
Sell 7.36 M USD
|
Roberts Jonathan C
EVP & Chief Operating Officer |
- 68482
|
107.5 USD |
3 years ago
Nov 03, 2021
|
Sell 10.3 M USD
|
Roberts Jonathan C
EVP & Chief Operating Officer |
- 108870
|
95 USD |
3 years ago
Nov 03, 2021
|
Sell 10.3 M USD
|
Roberts Jonathan C
EVP & Chief Operating Officer |
- 108870
|
95 USD |
3 years ago
Nov 01, 2021
|
Sell 2.53 M USD
|
Brennan Troyen A
EVP and Chief Medical Officer |
- 28159
|
90 USD |
3 years ago
Oct 26, 2021
|
Sell 172 K USD
|
Brennan Troyen A
EVP and Chief Medical Officer |
- 1955
|
88 USD |
3 years ago
Oct 26, 2021
|
Sell 7.11 M USD
|
Brennan Troyen A
EVP and Chief Medical Officer |
- 80802
|
88 USD |
3 years ago
Sep 02, 2021
|
Sell 228 K USD
|
Brennan Troyen A
EVP and Chief Medical Officer |
- 2625
|
87 USD |
3 years ago
Aug 05, 2021
|
Bought 239 K USD
|
LUDWIG EDWARD J
Director |
+ 3000
|
79.545 USD |
3 years ago
Jun 28, 2021
|
Sell 233 K USD
|
Lotvin Alan
EVP&President-PharmacyServices |
- 2781
|
83.67 USD |
3 years ago
Jun 15, 2021
|
Sell 5.81 M USD
|
Brennan Troyen A
EVP and Chief Medical Officer |
- 67552
|
86 USD |
3 years ago
Jun 07, 2021
|
Sell 3.26 M USD
|
Finke Daniel P
EVP/Pres, Health Care Benefits |
- 37594
|
86.6 USD |
3 years ago
May 10, 2021
|
Sell 9.41 M USD
|
Moriarty Thomas M
EVP & General Counsel |
- 109469
|
86 USD |
3 years ago
May 07, 2021
|
Sell 796 K USD
|
Brennan Troyen A
EVP and Chief Medical Officer |
- 9477
|
84 USD |
3 years ago
May 04, 2021
|
Sell 392 K USD
|
Boratto Eva C
EVP & CFO |
- 4905
|
80 USD |
3 years ago
Apr 21, 2021
|
Sell 7.78 M USD
|
Moriarty Thomas M
EVP & General Counsel |
- 101003
|
77 USD |
3 years ago
Apr 21, 2021
|
Sell 186 K USD
|
Moriarty Thomas M
EVP & General Counsel |
- 2420
|
77 USD |
3 years ago
Mar 31, 2021
|
Sell 407 K USD
|
Clark James David
SVP, Cont & Chief Acct Officer |
- 5350
|
76 USD |
3 years ago
Mar 29, 2021
|
Sell 4.79 M USD
|
Moriarty Thomas M
EVP & General Counsel |
- 62943
|
76.15 USD |
3 years ago
Mar 26, 2021
|
Sell 5.47 M USD
|
Roberts Jonathan C
EVP & Chief Operating Officer |
- 73433
|
74.49 USD |
3 years ago
Mar 26, 2021
|
Sell 20.2 M USD
|
MERLO LARRY J
Director |
- 270650
|
74.73 USD |
3 years ago
Mar 19, 2021
|
Sell 3.65 M USD
|
Moriarty Thomas M
EVP & General Counsel |
- 49211
|
74.15 USD |
3 years ago
Mar 16, 2021
|
Sell 1.41 M USD
|
Boratto Eva C
EVP & CFO |
- 18882
|
74.68 USD |
3 years ago
Feb 17, 2021
|
Bought 216 K USD
|
LUDWIG EDWARD J
Director |
+ 3000
|
72 USD |
3 years ago
Jan 19, 2021
|
Sell 4.84 M USD
|
MERLO LARRY J
President and CEO |
- 62893
|
77 USD |
3 years ago
Jan 12, 2021
|
Sell 1.94 M USD
|
Bisaccia Lisa
EVP and Chief HR Officer |
- 25177
|
77 USD |
3 years ago
Jan 08, 2021
|
Sell 1.94 M USD
|
Lotvin Alan
EVP and President-CVS Caremark |
- 25836
|
75 USD |
3 years ago
Jan 08, 2021
|
Sell 4.42 M USD
|
Brennan Troyen A
EVP and Chief Medical Officer |
- 58896
|
75 USD |
4 years ago
Nov 13, 2020
|
Sell 500 K USD
|
Lotvin Alan
EVP and President-CVS Caremark |
- 7138
|
70 USD |
4 years ago
Nov 10, 2020
|
Sell 1.5 M USD
|
Flum Joshua Matthew
EVP, ENT STRATEGY & DIGITAL |
- 21460
|
70 USD |
4 years ago
May 26, 2020
|
Sell 686 K USD
|
Mayhew Jonathan E.
EVP - Transformation |
- 10556
|
65 USD |
4 years ago
May 26, 2020
|
Sell 17.6 K USD
|
Clark James David
SVP, Cont & Chief Acct Officer |
- 270
|
65 USD |
4 years ago
May 11, 2020
|
Bought 316 K USD
|
Lotvin Alan
EVP and President-CVS Caremark |
+ 5000
|
63.135 USD |
4 years ago
Apr 28, 2020
|
Sell 405 K USD
|
Clark James David
SVP, Cont & Chief Acct Officer |
- 6234
|
65 USD |
4 years ago
Mar 30, 2020
|
Sell 182 K USD
|
Clark James David
SVP, Cont & Chief Acct Officer |
- 3030
|
60 USD |
4 years ago
Jan 15, 2020
|
Sell 19.9 M USD
|
MERLO LARRY J
President and CEO |
- 266476
|
74.79 USD |
4 years ago
Jan 08, 2020
|
Sell 4.18 M USD
|
Roberts Jonathan C
EVP & Chief Operating Officer |
- 57563
|
72.63 USD |
5 years ago
Nov 18, 2019
|
Sell 6.01 M USD
|
Lynch Karen S
EVP & Pres, Aetna Bus Unit |
- 80143
|
75 USD |
5 years ago
Nov 04, 2019
|
Sell 1.61 M USD
|
Brennan Troyen A
EVP and Chief Medical Officer |
- 23604
|
68 USD |
5 years ago
Sep 30, 2019
|
Sell 1.12 M USD
|
Flum Joshua Matthew
EVP, ENT STRATEGY & DIGITAL |
- 17703
|
63 USD |
5 years ago
Sep 12, 2019
|
Sell 528 K USD
|
Boratto Eva C
EVP & CFO |
- 8130
|
65 USD |